AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0053
-0.0007 (-11.67%)
May 26, 2026, 2:34 PM EST
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $1.89 million as of May 27, 2026. Its market cap has decreased by -11.34% in one year.
Market Cap
1.89M
Enterprise Value
n/a
Revenue
92.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 9, 2013, AXIM Biotechnologies's market cap has decreased from 1.98M to 1.89M, a decrease of -4.63%. That is a compound annual growth rate of -0.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 1.89M | -50.38% |
| Dec 31, 2025 | 3.81M | 528.02% |
| Dec 31, 2024 | 605.90K | -86.58% |
| Dec 29, 2023 | 4.52M | -12.57% |
| Dec 30, 2022 | 5.16M | -91.35% |
| Dec 31, 2021 | 59.71M | 10.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LakeShore Biopharma | 2.88M |
| ProtoKinetix | 2.74M |
| Eloxx Pharmaceuticals | 2.73M |
| Vaccinex | 2.68M |
| Hepion Pharmaceuticals | 2.56M |
| Enzolytics | 2.42M |
| VitaSpring Biomedical | 2.30M |
| CASI Pharmaceuticals | 2.26M |